Transdermal drug delivery: 30 + years of war and still fighting!

Journal of Controlled Release

Volumn 190, Issue , 2014, Pages 150-156

  Wiedersberg, Sandra ^a   Guy, Richard H ^b  

^a LTS Lohmann Therapie Systeme AG   (Germany)

^b University of Bath   (United Kingdom)

Author keywords

Controlled release; Skin barrier function; Transdermal drug delivery

Indexed keywords

TARGETED DRUG DELIVERY;

ACTIVE SPECIES; BARRIER FUNCTIONS; CONTROLLED RELEASE; PREFERRED ROUTES; REGULATORY APPROVALS; RESEARCH ACTIVITIES; SKIN BARRIER FUNCTIONS; TRANSDERMAL DRUG DELIVERY;

CONTROLLED DRUG DELIVERY;

BUPRENORPHINE; FENTANYL; GESTAGEN; GLUCOSE; GLYCERYL TRINITRATE; LIDOCAINE; NICOTINE PATCH; NORETHISTERONE; ROTIGOTINE; SUMATRIPTAN; DELAYED RELEASE FORMULATION; CLONIDINE; ESTRADIOL; GRANISETRON; LEVONORGESTREL; METHYLPHENIDATE; NORETHISTERONE ACETATE; RIVASTIGMINE; SCOPOLAMINE; TESTOSTERONE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG INDUSTRY; DRUG SOLUBILITY; HUMAN; IONTOPHORESIS; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN PENETRATION; SKIN PERMEABILITY; SKIN SENSITIVITY; STEADY STATE; STRATUM CORNEUM; THERMODYNAMICS; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH; ADMINISTRATION AND DOSAGE; DELAYED RELEASE FORMULATION; ECONOMICS; HISTORY; INTRADERMAL DRUG ADMINISTRATION; PHARMACOKINETICS; SKIN ABSORPTION; TRANSDERMAL DRUG DELIVERY SYSTEM;

ADMINISTRATION, CUTANEOUS; DELAYED-ACTION PREPARATIONS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; SKIN ABSORPTION;

EID: 84906787608     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.05.022     Document Type: Review

References (24)

1. R.H. Guy Transdermal drug delivery M. Schäfer-Korting, Drug Delivery, Handbook of Experimental Pharmacology 2010 Springer Berlin Heidelberg 399 410
2. M.R. Prausnitz, and R. Langer Transdermal drug delivery Nat. Biotechnol. 26 2008 1261 1268
3. G. Cleary Transdermal delivery systems: a medical rationale V. Shah, H. Maibach, Topical Drug Bioavailability, Bioequivalence, and Penetration 1993 Springer US 17 68
4. M.B. Delgado-Charro, and R.H. Guy Transdermal drug delivery A.M. Hillery, A.W. Lloyd, J. Swarbrick, Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists 2001 Harwood Academic Publishers London 207 236
5. A. Naik, Y.N. Kalia, and R.H. Guy Transdermal drug delivery: overcoming the skin's barrier function Pharm. Sci. Technol. Today 3 2000 318 326
6. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 2001 3 26 (Pubitemid 33653411)
7. J. Hadgraft, and M.E. Lane Passive transdermal drug delivery systems. Recent considerations and advances Am. J. Drug Deliv. 4 2006 153 160 (Pubitemid 44338314)
8. C. Waters The development of the rotigotine transdermal patch: a historical perspective Neurol. Clin. 31 2013 S37 S50
9. R.H. Guy, and J. Hadgraft Rate control in transdermal drug delivery? Int. J. Pharm. 82 1992 R1 R6
10. J. Hadgraft, and R.H. Guy Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies R.H. Guy, J. Hadgraft, Transdermal Drug Delivery 2003 Marcel Dekker New York 1 23
11. S. Mitragotri, Y.G. Anissimov, A.L. Bunge, H.F. Frasch, R.H. Guy, J. Hadgraft, G.B. Kasting, M.E. Lane, and M.S. Roberts Mathematical models of skin permeability: an overview Int. J. Pharm. 418 2011 115 129
12. R.O. Potts, and R.H. Guy Predicting skin permeability Pharm. Res. 9 1992 663 669
13. R.L. Cleek, and A.L. Bunge A new method for estimating dermal absorption from chemical exposure. 1. General approach Pharm. Res. 10 1993 497 506 (Pubitemid 23113039)
14. ChemSpider Available at http://www.chemspider.com
15. Virtual Computational Chemistry Laboratory Available at http://www.vcclab.org
16. R.H. Guy Predicting the rate and extent of fragrance chemical absoprtion into and through the skin Chem. Res. Toxicol. 23 2010 864 870
17. Noven Pharmaceuticals Available at http://www.noven.com
18. T. Gratieri, D. Kalaria, and Y.N. Kalia Non-invasive iontophoretic delivery of peptides and proteins across the skin Expert Opin. Drug Deliv. 8 2011 645 663
19. C.M. Schoellhammer, D. Blankschtein, and R. Langer Skin permeabilization for transdermal drug delivery: recent advances and future prospects Expert Opin. Drug Deliv. 11 2014 393 407
20. T.M. Tuan-Mahmood, M.T. McCrudden, B.M. Torrisi, E. McAlister, M.J. Garland, T.R. Singh, and R.F. Donnelly Microneedles for intradermal and transdermal drug delivery Eur. J. Pharm. Sci. 50 2013 623 637
21. S. Scheiblhofer, J. Thalhamer, and R. Weiss Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines Expert Opin. Drug Deliv. 10 2013 761 773
22. N. Singh, H. Kalluri, A. Herwadkar, A. Badkar, and A.K. Banga Transcending the skin barrier to deliver peptides and proteins using active technologies Crit. Rev. Ther. Drug Carrier Syst. 29 2012 265 298
23. K. van der Maaden, W. Jiskoot, and J. Bouwstra Microneedle technologies for (trans)dermal drug and vaccine delivery J. Control. Release 161 2012 645 655
24. Y.C. Kim, J.H. Park, and M.R. Prausnitz Microneedles for drug and vaccine delivery Adv. Drug Deliv. Rev. 64 2012 1547 1568